ID   AP2M1_RAT               Reviewed;         435 AA.
AC   P84092; P20172; P53679;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   24-JUL-2024, entry version 171.
DE   RecName: Full=AP-2 complex subunit mu;
DE   AltName: Full=AP-2 mu chain;
DE   AltName: Full=Adaptor protein complex AP-2 subunit mu;
DE   AltName: Full=Adaptor-related protein complex 2 subunit mu;
DE   AltName: Full=Clathrin assembly protein complex 2 mu medium chain;
DE   AltName: Full=Clathrin coat assembly protein AP50;
DE   AltName: Full=Clathrin coat-associated protein AP50;
DE   AltName: Full=Mu2-adaptin;
DE   AltName: Full=Plasma membrane adaptor AP-2 50 kDa protein;
GN   Name=Ap2m1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3148444; DOI=10.1089/dna.1988.7.663;
RA   Thurieau C., Brosius J., Burne C., Jolles P., Keen J.H., Mattaliano R.J.,
RA   Chow E.P., Ramachandran K.L., Kirchhausen T.;
RT   "Molecular cloning and complete amino acid sequence of AP50, an assembly
RT   protein associated with clathrin-coated vesicles.";
RL   DNA 7:663-669(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH EGFR AND TTGN1, AND MUTAGENESIS OF ASP-176 AND TRP-421.
RX   PubMed=10228163; DOI=10.1093/emboj/18.9.2489;
RA   Nesterov A., Carter R.E., Sorkina T., Gill G.N., Sorkin A.;
RT   "Inhibition of the receptor-binding function of clathrin adaptor protein
RT   AP-2 by dominant-negative mutant mu2 subunit and its effects on
RT   endocytosis.";
RL   EMBO J. 18:2489-2499(1999).
RN   [4]
RP   FUNCTION OF THE AP-2 COMPLEX, AND MUTAGENESIS OF THR-156.
RX   PubMed=11516654; DOI=10.1016/s0960-9822(01)00240-8;
RA   Olusanya O., Andrews P.D., Swedlow J.R., Smythe E.;
RT   "Phosphorylation of threonine 156 of the mu2 subunit of the AP2 complex is
RT   essential for endocytosis in vitro and in vivo.";
RL   Curr. Biol. 11:896-900(2001).
RN   [5]
RP   FUNCTION OF THE AP-2 COMPLEX IN CLATHRIN-MEDIATED ENDOCYTOSIS.
RX   PubMed=14745134; DOI=10.1247/csf.28.419;
RA   Nakatsu F., Ohno H.;
RT   "Adaptor protein complexes as the key regulators of protein sorting in the
RT   post-Golgi network.";
RL   Cell Struct. Funct. 28:419-429(2003).
RN   [6]
RP   FUNCTION OF THE AP-2 COMPLEX IN CLATHRIN-MEDIATED ENDOCYTOSIS.
RX   PubMed=15473838; DOI=10.1146/annurev.cellbio.20.010403.104543;
RA   Owen D.J., Collins B.M., Evans P.R.;
RT   "Adaptors for clathrin coats: structure and function.";
RL   Annu. Rev. Cell Dev. Biol. 20:153-191(2004).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 159-435 IN COMPLEX WITH EGFR
RP   INTERNALIZATION SIGNAL.
RX   PubMed=9812899; DOI=10.1126/science.282.5392.1327;
RA   Owen D.J., Evans P.R.;
RT   "A structural explanation for the recognition of tyrosine-based endocytotic
RT   signals.";
RL   Science 282:1327-1332(1998).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (3 ANGSTROMS) OF 158-435 IN COMPLEX WITH SELP
RP   INTERNALIZATION SIGNAL.
RX   PubMed=11247301; DOI=10.1034/j.1600-0854.2001.020205.x;
RA   Owen D.J., Setiadi H., Evans P.R., McEver R.P., Green S.A.;
RT   "A third specificity-determining site in mu 2 adaptin for sequences
RT   upstream of Yxx phi sorting motifs.";
RL   Traffic 2:105-110(2001).
RN   [9] {ECO:0007744|PDB:2VGL}
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) IN COMPLEX WITH AP2B1; AP2A2; AP2S1
RP   AND INOSITOL HEXAKISPHOSPHATE.
RX   PubMed=12086608; DOI=10.1016/s0092-8674(02)00735-3;
RA   Collins B.M., McCoy A.J., Kent H.M., Evans P.R., Owen D.J.;
RT   "Molecular architecture and functional model of the endocytic AP2
RT   complex.";
RL   Cell 109:523-535(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 260-435 IN COMPLEX WITH EGFR
RP   INTERNALIZATION SIGNAL.
RX   PubMed=12121421; DOI=10.1034/j.1600-0854.2002.30808.x;
RA   Boll W., Rapoport I., Brunner C., Modis Y., Prehn S., Kirchhausen T.;
RT   "The mu2 subunit of the clathrin adaptor AP-2 binds to FDNPVY and YppO
RT   sorting signals at distinct sites.";
RL   Traffic 3:590-600(2002).
RN   [11] {ECO:0007744|PDB:2BP5}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH P2RX4 PEPTIDE, AND
RP   FUNCTION.
RX   PubMed=15985462; DOI=10.1242/jcs.02451;
RA   Royle S.J., Qureshi O.S., Bobanovic L.K., Evans P.R., Owen D.J.,
RA   Murrell-Lagnado R.D.;
RT   "Non-canonical YXXGPhi endocytic motifs: recognition by AP2 and
RT   preferential utilization in P2X4 receptors.";
RL   J. Cell Sci. 118:3073-3080(2005).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 1-435 IN COMPLEX WITH AP2A2;
RP   AP2B1; AP2S1 AND CD4 INTERNALIZATION SIGNAL.
RX   PubMed=19140243; DOI=10.1038/nature07422;
RA   Kelly B.T., McCoy A.J., Spaete K., Miller S.E., Evans P.R., Hoening S.,
RA   Owen D.J.;
RT   "A structural explanation for the binding of endocytic dileucine motifs by
RT   the AP2 complex.";
RL   Nature 456:976-979(2008).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 170-435 IN COMPLEX WITH DVL2,
RP   FUNCTION, AND INTERACTION WITH DVL2.
RX   PubMed=20947020; DOI=10.1016/j.str.2010.07.010;
RA   Yu A., Xing Y., Harrison S.C., Kirchhausen T.;
RT   "Structural analysis of the interaction between Dishevelled2 and clathrin
RT   AP-2 adaptor, a critical step in noncanonical Wnt signaling.";
RL   Structure 18:1311-1320(2010).
RN   [14] {ECO:0007744|PDB:4UQI}
RP   X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) IN COMPLEX WITH AP2A2; AP2B1; AP2S1
RP   AND INOSITOL HEXAKISPHOSPHATE.
RX   PubMed=25061211; DOI=10.1126/science.1254836;
RA   Kelly B.T., Graham S.C., Liska N., Dannhauser P.N., Honing S.,
RA   Ungewickell E.J., Owen D.J.;
RT   "Clathrin adaptors. AP2 controls clathrin polymerization with a membrane-
RT   activated switch.";
RL   Science 345:459-463(2014).
CC   -!- FUNCTION: Component of the adaptor protein complex 2 (AP-2)
CC       (PubMed:14745134, PubMed:15473838). Adaptor protein complexes function
CC       in protein transport via transport vesicles in different membrane
CC       traffic pathways (PubMed:14745134, PubMed:15473838). Adaptor protein
CC       complexes are vesicle coat components and appear to be involved in
CC       cargo selection and vesicle formation (PubMed:14745134,
CC       PubMed:15473838). AP-2 is involved in clathrin-dependent endocytosis in
CC       which cargo proteins are incorporated into vesicles surrounded by
CC       clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion
CC       with the early endosome (PubMed:14745134, PubMed:15473838). The
CC       clathrin lattice serves as a mechanical scaffold but is itself unable
CC       to bind directly to membrane components (PubMed:14745134,
CC       PubMed:15473838). Clathrin-associated adaptor protein (AP) complexes
CC       which can bind directly to both the clathrin lattice and to the lipid
CC       and protein components of membranes are considered to be the major
CC       clathrin adaptors contributing the CCV formation (PubMed:14745134,
CC       PubMed:15473838). AP-2 also serves as a cargo receptor to selectively
CC       sort the membrane proteins involved in receptor-mediated endocytosis
CC       (PubMed:14745134, PubMed:15473838). AP-2 seems to play a role in the
CC       recycling of synaptic vesicle membranes from the presynaptic surface
CC       (By similarity). AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-
CC       X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of
CC       transmembrane cargo molecules (PubMed:15985462). AP-2 may also play a
CC       role in maintaining normal post-endocytic trafficking through the ARF6-
CC       regulated, non-clathrin pathway (By similarity). During long-term
CC       potentiation in hippocampal neurons, AP-2 is responsible for the
CC       endocytosis of ADAM10 (By similarity). The AP-2 mu (AP2M1) subunit
CC       binds to transmembrane cargo proteins; it recognizes the Y-X-X-Phi
CC       motifs (PubMed:15985462). The surface region interacting with to the Y-
CC       X-X-Phi motif is inaccessible in cytosolic AP-2, but becomes accessible
CC       through a conformational change following phosphorylation of AP-2 mu
CC       subunit at Thr-156 in membrane-associated AP-2 (PubMed:11516654,
CC       PubMed:15985462). The membrane-specific phosphorylation event appears
CC       to involve assembled clathrin which activates the AP-2 mu kinase AAK1
CC       (By similarity). Plays a role in endocytosis of frizzled family members
CC       upon Wnt signaling (PubMed:20947020). {ECO:0000250|UniProtKB:Q96CW1,
CC       ECO:0000269|PubMed:11516654, ECO:0000269|PubMed:14745134,
CC       ECO:0000269|PubMed:15473838, ECO:0000269|PubMed:15985462,
CC       ECO:0000269|PubMed:20947020}.
CC   -!- SUBUNIT: Adaptor protein complex 2 (AP-2) is a heterotetramer composed
CC       of two large adaptins (alpha-type subunit AP2A1 or AP2A2 and beta-type
CC       subunit AP2B1), a medium adaptin (mu-type subunit AP2M1) and a small
CC       adaptin (sigma-type subunit AP2S1) (PubMed:19140243). Interacts with
CC       ATP6V1H and MEGF10 (By similarity). Interacts with EGFR and TTGN1
CC       (PubMed:10228163, PubMed:12121421, PubMed:9812899). Interacts with F2R
CC       (By similarity). Interacts with PIP5K1C; tyrosine phosphorylation of
CC       PIP5K1C weakens the interaction (By similarity). Interacts with
CC       KIAA0319; required for clathrin-mediated endocytosis of KIAA0319 (By
CC       similarity). Interacts with DVL2 (via DEP domain) (PubMed:20947020).
CC       Interacts with KCNQ1; mediates estrogen-induced internalization via
CC       clathrin-coated vesicles (By similarity). Interacts with P2RX4 (via
CC       internalization motif) (PubMed:15985462). Together with AP2A1 or AP2A2
CC       and AP2B1, it interacts with ADAM10; this interaction facilitates
CC       ADAM10 endocytosis from the plasma membrane during long-term
CC       potentiation in hippocampal neurons (By similarity). Probably interacts
CC       with ACE2 (via endocytic sorting signal motif); the interaction is
CC       inhibited by ACE2 phosphorylation (By similarity). Interacts with
CC       RALBP1; the interaction is direct (By similarity). Interacts with
CC       TMEM106B (via N-terminus) (By similarity).
CC       {ECO:0000250|UniProtKB:P84091, ECO:0000250|UniProtKB:Q96CW1,
CC       ECO:0000269|PubMed:10228163, ECO:0000269|PubMed:12121421,
CC       ECO:0000269|PubMed:15985462, ECO:0000269|PubMed:19140243,
CC       ECO:0000269|PubMed:20947020, ECO:0000269|PubMed:9812899}.
CC   -!- INTERACTION:
CC       P84092; P19491: Gria2; NbExp=2; IntAct=EBI-297693, EBI-77718;
CC       P84092; P19814: Ttgn1; NbExp=4; IntAct=EBI-297693, EBI-541446;
CC       P84092; P63010: AP2B1; Xeno; NbExp=4; IntAct=EBI-297693, EBI-432924;
CC       P84092; Q60838: Dvl2; Xeno; NbExp=4; IntAct=EBI-297693, EBI-641940;
CC       P84092; P17301: ITGA2; Xeno; NbExp=2; IntAct=EBI-297693, EBI-702960;
CC       P84092; P13612: ITGA4; Xeno; NbExp=2; IntAct=EBI-297693, EBI-703044;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q96CW1}.
CC       Membrane, coated pit {ECO:0000250|UniProtKB:Q96CW1}; Peripheral
CC       membrane protein {ECO:0000250|UniProtKB:Q96CW1}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q96CW1}. Note=AP-2 appears to be excluded from
CC       internalizing CCVs and to disengage from sites of endocytosis seconds
CC       before internalization of the nascent CCV.
CC       {ECO:0000250|UniProtKB:P84091}.
CC   -!- TISSUE SPECIFICITY: Detected in brain.
CC   -!- PTM: Phosphorylation at Thr-156 increases the affinity of the AP-2
CC       complex for cargo membrane proteins during the initial stages of
CC       endocytosis. {ECO:0000250|UniProtKB:Q96CW1}.
CC   -!- SIMILARITY: Belongs to the adaptor complexes medium subunit family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M23674; AAA72731.1; -; mRNA.
DR   EMBL; BC087724; AAH87724.1; -; mRNA.
DR   PIR; A31596; A31596.
DR   RefSeq; NP_446289.1; NM_053837.1.
DR   PDB; 1BW8; X-ray; 2.65 A; A=122-435.
DR   PDB; 1BXX; X-ray; 2.70 A; A=158-435.
DR   PDB; 1HES; X-ray; 3.00 A; A=158-435.
DR   PDB; 1I31; X-ray; 2.50 A; A=122-435.
DR   PDB; 2BP5; X-ray; 2.80 A; M=1-435.
DR   PDB; 2JKR; X-ray; 2.98 A; M/U=1-435.
DR   PDB; 2JKT; X-ray; 3.40 A; M/U=1-435.
DR   PDB; 2PR9; X-ray; 2.51 A; A=158-435.
DR   PDB; 2VGL; X-ray; 2.59 A; M=1-435.
DR   PDB; 2XA7; X-ray; 3.10 A; M=1-435.
DR   PDB; 3H85; X-ray; 2.60 A; A=158-435.
DR   PDB; 3ML6; X-ray; 3.50 A; A/B/C/D/E/F=170-435.
DR   PDB; 4UQI; X-ray; 2.79 A; M=1-435.
DR   PDB; 5C7Z; X-ray; 2.77 A; A=159-435.
DR   PDB; 5FPI; X-ray; 2.77 A; A=1-435.
DR   PDB; 5WRK; X-ray; 2.62 A; A=158-435.
DR   PDB; 5WRL; X-ray; 3.10 A; A=158-435.
DR   PDB; 5WRM; X-ray; 2.60 A; A=158-435.
DR   PDB; 6QH5; X-ray; 2.56 A; M/N=1-435.
DR   PDB; 6QH6; X-ray; 5.00 A; N=1-435.
DR   PDB; 6RH6; NMR; -; B=149-163.
DR   PDB; 6YAE; EM; 3.90 A; M=1-435.
DR   PDB; 6YAF; EM; 9.10 A; M=1-435.
DR   PDB; 6YAH; EM; 10.20 A; M=1-435.
DR   PDB; 7OFP; X-ray; 1.92 A; A/B=158-435.
DR   PDB; 7OG1; X-ray; 3.25 A; CCC/MMM=1-435.
DR   PDB; 7OHO; X-ray; 2.88 A; MMM=1-435.
DR   PDB; 7OHZ; X-ray; 2.27 A; A/B=158-435.
DR   PDB; 7OI5; X-ray; 2.61 A; B/D=158-435.
DR   PDB; 7OIQ; X-ray; 1.85 A; AAA/BBB=158-435.
DR   PDB; 7Z5C; EM; 4.16 A; M=1-435.
DR   PDBsum; 1BW8; -.
DR   PDBsum; 1BXX; -.
DR   PDBsum; 1HES; -.
DR   PDBsum; 1I31; -.
DR   PDBsum; 2BP5; -.
DR   PDBsum; 2JKR; -.
DR   PDBsum; 2JKT; -.
DR   PDBsum; 2PR9; -.
DR   PDBsum; 2VGL; -.
DR   PDBsum; 2XA7; -.
DR   PDBsum; 3H85; -.
DR   PDBsum; 3ML6; -.
DR   PDBsum; 4UQI; -.
DR   PDBsum; 5C7Z; -.
DR   PDBsum; 5FPI; -.
DR   PDBsum; 5WRK; -.
DR   PDBsum; 5WRL; -.
DR   PDBsum; 5WRM; -.
DR   PDBsum; 6QH5; -.
DR   PDBsum; 6QH6; -.
DR   PDBsum; 6RH6; -.
DR   PDBsum; 6YAE; -.
DR   PDBsum; 6YAF; -.
DR   PDBsum; 6YAH; -.
DR   PDBsum; 7OFP; -.
DR   PDBsum; 7OG1; -.
DR   PDBsum; 7OHO; -.
DR   PDBsum; 7OHZ; -.
DR   PDBsum; 7OI5; -.
DR   PDBsum; 7OIQ; -.
DR   PDBsum; 7Z5C; -.
DR   AlphaFoldDB; P84092; -.
DR   EMDB; EMD-10747; -.
DR   EMDB; EMD-10748; -.
DR   EMDB; EMD-10751; -.
DR   EMDB; EMD-14517; -.
DR   SMR; P84092; -.
DR   BioGRID; 250498; 11.
DR   CORUM; P84092; -.
DR   DIP; DIP-29761N; -.
DR   IntAct; P84092; 24.
DR   MINT; P84092; -.
DR   STRING; 10116.ENSRNOP00000070202; -.
DR   iPTMnet; P84092; -.
DR   PhosphoSitePlus; P84092; -.
DR   SwissPalm; P84092; -.
DR   jPOST; P84092; -.
DR   PaxDb; 10116-ENSRNOP00000054900; -.
DR   Ensembl; ENSRNOT00000088821.2; ENSRNOP00000070202.1; ENSRNOG00000001709.8.
DR   Ensembl; ENSRNOT00055007791; ENSRNOP00055005873; ENSRNOG00055004882.
DR   Ensembl; ENSRNOT00060020201; ENSRNOP00060015872; ENSRNOG00060011929.
DR   Ensembl; ENSRNOT00065006162; ENSRNOP00065004397; ENSRNOG00065004219.
DR   GeneID; 116563; -.
DR   KEGG; rno:116563; -.
DR   AGR; RGD:620135; -.
DR   CTD; 1173; -.
DR   RGD; 620135; Ap2m1.
DR   eggNOG; KOG0938; Eukaryota.
DR   GeneTree; ENSGT00940000159223; -.
DR   HOGENOM; CLU_026996_5_2_1; -.
DR   InParanoid; P84092; -.
DR   OMA; VWKIPRI; -.
DR   OrthoDB; 6959at2759; -.
DR   PhylomeDB; P84092; -.
DR   TreeFam; TF300722; -.
DR   Reactome; R-RNO-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-RNO-190873; Gap junction degradation.
DR   Reactome; R-RNO-196025; Formation of annular gap junctions.
DR   Reactome; R-RNO-2132295; MHC class II antigen presentation.
DR   Reactome; R-RNO-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-RNO-437239; Recycling pathway of L1.
DR   Reactome; R-RNO-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-RNO-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-RNO-8964038; LDL clearance.
DR   EvolutionaryTrace; P84092; -.
DR   PRO; PR:P84092; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001709; Expressed in frontal cortex and 19 other cell types or tissues.
DR   ExpressionAtlas; P84092; baseline and differential.
DR   GO; GO:0030122; C:AP-2 adaptor complex; IDA:CAFA.
DR   GO; GO:0005905; C:clathrin-coated pit; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IBA:GO_Central.
DR   GO; GO:0098894; C:extrinsic component of presynaptic endocytic zone membrane; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:SynGO.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0035615; F:clathrin adaptor activity; IBA:GO_Central.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:BHF-UCL.
DR   GO; GO:0005048; F:signal sequence binding; IDA:BHF-UCL.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; ISO:RGD.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; IMP:RGD.
DR   GO; GO:1900244; P:positive regulation of synaptic vesicle endocytosis; IMP:RGD.
DR   GO; GO:0098884; P:postsynaptic neurotransmitter receptor internalization; IDA:SynGO.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:RGD.
DR   GO; GO:0031623; P:receptor internalization; ISO:RGD.
DR   GO; GO:0097494; P:regulation of vesicle size; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IDA:SynGO.
DR   GO; GO:0006900; P:vesicle budding from membrane; ISO:RGD.
DR   CDD; cd09251; AP-2_Mu2_Cterm; 1.
DR   CDD; cd14836; AP2_Mu_N; 1.
DR   DisProt; DP00455; -.
DR   Gene3D; 3.30.450.60; -; 1.
DR   Gene3D; 2.60.40.1170; Mu homology domain, subdomain B; 2.
DR   IDEAL; IID50122; -.
DR   InterPro; IPR050431; Adaptor_comp_med_subunit.
DR   InterPro; IPR036168; AP2_Mu_C_sf.
DR   InterPro; IPR043532; AP2_Mu_N.
DR   InterPro; IPR022775; AP_mu_sigma_su.
DR   InterPro; IPR001392; Clathrin_mu.
DR   InterPro; IPR018240; Clathrin_mu_CS.
DR   InterPro; IPR011012; Longin-like_dom_sf.
DR   InterPro; IPR028565; MHD.
DR   InterPro; IPR043512; Mu2_C.
DR   PANTHER; PTHR10529; AP COMPLEX SUBUNIT MU; 1.
DR   PANTHER; PTHR10529:SF236; AP-2 COMPLEX SUBUNIT MU; 1.
DR   Pfam; PF00928; Adap_comp_sub; 1.
DR   Pfam; PF01217; Clat_adaptor_s; 1.
DR   PIRSF; PIRSF005992; Clathrin_mu; 1.
DR   PRINTS; PR00314; CLATHRINADPT.
DR   SUPFAM; SSF49447; Second domain of Mu2 adaptin subunit (ap50) of ap2 adaptor; 1.
DR   SUPFAM; SSF64356; SNARE-like; 1.
DR   PROSITE; PS00990; CLAT_ADAPTOR_M_1; 1.
DR   PROSITE; PS00991; CLAT_ADAPTOR_M_2; 1.
DR   PROSITE; PS51072; MHD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Coated pit; Endocytosis; Lipid-binding;
KW   Membrane; Phosphoprotein; Protein transport; Reference proteome; Transport.
FT   CHAIN           1..435
FT                   /note="AP-2 complex subunit mu"
FT                   /id="PRO_0000193776"
FT   DOMAIN          170..434
FT                   /note="MHD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00404"
FT   BINDING         341
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   BINDING         345
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   BINDING         354
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT                   /evidence="ECO:0000305|PubMed:12086608,
FT                   ECO:0000305|PubMed:25061211, ECO:0007744|PDB:2VGL,
FT                   ECO:0007744|PDB:4UQI"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96CW1"
FT   MOD_RES         156
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96CW1"
FT   MUTAGEN         156
FT                   /note="T->A: Inhibits endocytosis by AP-2; no effect on
FT                   membrane association of AP-2."
FT                   /evidence="ECO:0000269|PubMed:11516654"
FT   MUTAGEN         176
FT                   /note="D->A: Abolishes interaction with TTGN1 and EGFR."
FT                   /evidence="ECO:0000269|PubMed:10228163"
FT   MUTAGEN         421
FT                   /note="W->A: Abolishes interaction with TTGN1 and EGFR."
FT                   /evidence="ECO:0000269|PubMed:10228163"
FT   STRAND          4..8
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          14..19
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          21..23
FT                   /evidence="ECO:0007829|PDB:2VGL"
FT   HELIX           26..35
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   TURN            36..38
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:4UQI"
FT   STRAND          46..50
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          53..60
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   STRAND          63..71
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           75..93
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           98..103
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           105..115
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           126..132
FT                   /evidence="ECO:0007829|PDB:6QH5"
FT   HELIX           145..156
FT                   /evidence="ECO:0007829|PDB:2XA7"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:2XA7"
FT   STRAND          172..185
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          191..205
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          207..209
FT                   /evidence="ECO:0007829|PDB:1I31"
FT   STRAND          211..219
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   HELIX           221..223
FT                   /evidence="ECO:0007829|PDB:7OI5"
FT   STRAND          238..240
FT                   /evidence="ECO:0007829|PDB:2JKR"
FT   STRAND          244..248
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          252..254
FT                   /evidence="ECO:0007829|PDB:2VGL"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   TURN            259..261
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          262..265
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          269..279
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          287..296
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   TURN            297..299
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          300..309
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          316..325
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          330..345
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          350..361
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          363..372
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:1I31"
FT   STRAND          386..394
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   TURN            396..398
FT                   /evidence="ECO:0007829|PDB:2XA7"
FT   STRAND          401..408
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   TURN            409..412
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   HELIX           415..417
FT                   /evidence="ECO:0007829|PDB:7OFP"
FT   STRAND          418..433
FT                   /evidence="ECO:0007829|PDB:7OFP"
SQ   SEQUENCE   435 AA;  49655 MW;  82803219BA279954 CRC64;
     MIGGLFIYNH KGEVLISRVY RDDIGRNAVD AFRVNVIHAR QQVRSPVTNI ARTSFFHVKR
     SNIWLAAVTK QNVNAAMVFE FLYKMCDVMA AYFGKISEEN IKNNFVLIYE LLDEILDFGY
     PQNSETGALK TFITQQGIKS QHQTKEEQSQ ITSQVTGQIG WRREGIKYRR NELFLDVLES
     VNLLMSPQGQ VLSAHVSGRV VMKSYLSGMP ECKFGMNDKI VIEKQGKGTA DETSKSGKQS
     IAIDDCTFHQ CVRLSKFDSE RSISFIPPDG EFELMRYRTT KDIILPFRVI PLVREVGRTK
     LEVKVVIKSN FKPSLLAQKI EVRIPTPLNT SGVQVICMKG KAKYKASENA IVWKIKRMAG
     MKESQISAEI ELLPTNDKKK WARPPISMNF EVPFAPSGLK VRYLKVFEPK LNYSDHDVIK
     WVRYIGRSGI YETRC
//
